Guilianne Rose Servano

Guilianne Servano practices at UCLA West Valley Medical Center in West Hills, California, part of University of California Health.

Guilianne Servano's NPI, 1598008005, was assigned on April 3, 2013. Guilianne Servano graduated from Temple University School of Medicine in 2013. Guilianne Servano holds California license A134326.

Guilianne Servano's primary practice is UCLA West Valley Medical Center, at 7300 Medical Center Dr, West Hills, CA 91307 in Los Angeles County. The practice phone is (818) 676-4000.

Guilianne Servano's primary practice is UCLA West Valley Medical Center in West Hills, California, part of University of California Health. Guilianne Servano is also affiliated with Olive View-UCLA Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Guilianne Servano to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Guilianne Servano practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Guilianne Servano's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Guilianne Servano is licensed in California.

CMS data shows 368 Medicare services from Guilianne Servano across 5 procedure codes in 2024, for 132 Medicare patients. Medicare paid $36,949 for them.

CMS counts 132 Medicare patients who saw Guilianne Servano in 2024. The largest group is 75 to 84, with 48 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 39% are also on Medicaid. Their average risk score is 2.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Guilianne Servano's median patient age at 63, with 45% women.

In 2024, Guilianne Servano wrote 225 Medicare Part D claims for 96 patients. 90% of them were for generic drugs. CMS names the drug for 23 of them, across 2 drugs with 11 or more claims each, at $203 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Guilianne Servano for performance year 2024, reported as part of a group. Guilianne Servano accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Guilianne Servano graduated from Temple University School of Medicine in 2013.